In response to the U.S. Food and Drug Administration’s (FDA) groundbreaking decision to authorize Florida’s drug importation program, Network of Advanced Specialty Healthcare (NASH) reaffirms its commitment to providing safe, high-quality, cost-effective specialty pharmacy solutions.
Key Highlights:
With this decision, FDA officially authorizes Florida’s proposal to import certain prescription drugs from Canada. This marks the first state program approved under Section 804 of the Federal Food, Drug, and Cosmetic Act.
- Purpose: to lower prescription drug costs for Americans while maintaining strict public health and safety standards.
-
The Florida program is authorized for two years (beginning from the date the FDA is notified of the first shipment).
-
This follows President Biden’s Executive Order (EO) on Promoting Competition, which encouraged the FDA to collaborate with states and tribes on cost-reduction plans.
NASH has long recognized that drug importation is an important part of reshaping the healthcare landscape. We partner with pharmacies in tier 1 healthcare countries, and work with brokers, self-insured employer groups, third-party administrators to help manage skyrocketing drug costs. Our solutions ensure the members have access to needed medications through personal importation. NASH’s carefully selected international partners are distinguished by their commitment to patient-centered care and stringent quality standards.
“NASH applauds the FDA’s decision to authorize Florida’s Canadian drug importation program. It underscores what we already know — drug prices in the U.S. are too high,” said NASH CEO Michael Agostino. “This represents a transformative moment in the pharmaceutical landscape. NASH isn’t just adapting to these changes, we’re setting the pace, ensuring patients receive the best in quality and price.”
Shipments to Florida as a result of this authorization are pending and likely to face many obstacles. NASH continues to actively lower costs for patients with affordable, high-quality medications. To learn more, email inquiries@NASHcares.com or call 833-833-6204.